Interestingly, both of our studies detected novel CXCL12-responsive AKT substrates, PDCD4 (pS457) [89] and AKT1S1 (pT246) (Figure 3A), underscoring the potential role of AKT signaling and leukemias [90]. The gene discussed is CXCL12; the disease is leukemia.